Myasthenia gravis constitutes chronic autoimmune disease that primarily affects the neuromuscular junction. This junction mediates the conveyance of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system erroneously attacks these receptors, resulting weakness and fatigue in the skeletal tissues. The manif